Patents by Inventor Barry Kiely

Barry Kiely has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulation comprising a bacterial strain
    Publication number: 20060088514
    Abstract: An injectable formulation of a bacterial strain such as a Lactobacillus salivarius strain is useful in treating of inflammatory disorders such as colitis or arthritis.
    Type: Application
    Filed: September 29, 2005
    Publication date: April 27, 2006
    Inventors: Liam O'Mahony, Fergus Shanahan, Barry Kiely, John Collins, Gerald O'Sullivan
  • Probiotic lactobacillus salivarius strains
    Publication number: 20060078547
    Abstract: A Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome.
    Type: Application
    Filed: April 14, 2005
    Publication date: April 13, 2006
    Inventors: John Collins, Gerald O'Sullivan, Liam O'Mahony, Fergus Shanahan, Barry Kiely
  • Methods of use of probiotic bifidobacteria for companion animals
    Publication number: 20050175598
    Abstract: According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Bifidobacteria.
    Type: Application
    Filed: December 15, 2004
    Publication date: August 11, 2005
    Applicant: The Procter & Gamble Company
    Inventors: Thomas Boileau, Michael Ceddia, Gary Davenport, Barry Kiely, Liam O'Mahony, Gregory Sunvold, Mark Tetrick, Robert Vickers
  • Canine probiotic Lactobacilli
    Publication number: 20050158293
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
    Type: Application
    Filed: December 15, 2004
    Publication date: July 21, 2005
    Applicant: The Procter & Gamble Company
    Inventors: Thomas Boileau, Michael Ceddia, John Collins, Gary Davenport, Barry Kiely, Liam O'Mahony, Gregory Sunvold, Mark Tetrick, Robert Vickers
  • Canine probiotic Bifidobacteria pseudolongum
    Publication number: 20050158294
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
    Type: Application
    Filed: December 15, 2004
    Publication date: July 21, 2005
    Applicant: The Procter & Gamble Company
    Inventors: Thomas Boileau, Michael Ceddia, John Collins, Gary Davenport, Barry Kiely, Liam O'Mahony, Gregory Sunvold, Mark Tetrick, Robert Vickers
  • Canine probiotic Bifidobacteria globosum
    Publication number: 20050152884
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
    Type: Application
    Filed: December 15, 2004
    Publication date: July 14, 2005
    Applicant: The Procter & Gamble Company
    Inventors: Thomas Boileau, Michael Ceddia, John Collins, Gary Davenport, Barry Kiely, Liam O'Mahony, Gregory Sunvold, Mark Tetrick, Robert Vickers
  • Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
    Publication number: 20040265279
    Abstract: A method of treating a disorder characterized by hypothalamic-pituitary-adrenal axis over-activity comprising administering to a subject a probiotic bacterium.
    Type: Application
    Filed: May 6, 2004
    Publication date: December 30, 2004
    Inventors: Timothy Dinan, Liam O'Mahony, Barry Kiely, Eamonn Quigley, Fergus Shanahan, John Kevin Collins
  • Probiotic lactobacillus casei strains
    Publication number: 20030113306
    Abstract: A Lactobacillus casei strain or a mutant or variant thereof isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. In particular a Lactobacillus casei strain, AH101, AH104, AH111, AH112 or AH113 or mutants or variants are thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome.
    Type: Application
    Filed: July 25, 2002
    Publication date: June 19, 2003
    Inventors: John Kevin Collins, Gerald Christopher O'sullivan, Liam O'Mahony, Fergus Shanahan, Barry Kiely
  • Probiotic bifidobacterium strains
    Publication number: 20030092163
    Abstract: A Bifidobacterium strain, AH208, AH209, AH210, AH211, AH212 or AH214 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome.
    Type: Application
    Filed: July 25, 2002
    Publication date: May 15, 2003
    Inventors: John Kevin Collins, Gerald Christopher O'Sullivan, Liam O'Mahony, Fergus Shanahan, Barry Kiely
  • Probiotic lactobacillus salivarius strains
    Publication number: 20030091549
    Abstract: A Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome.
    Type: Application
    Filed: July 26, 2002
    Publication date: May 15, 2003
    Inventors: John Kevin Collins, Gerald Christopher O'Sullivan, Liam O'Mahony, Fergus Shanahan, Barry Kiely